綠盟科技(300369.SZ):清華控股擬向合肥建投轉讓啟迪控股14.84%股份
格隆匯 11 月 5日丨綠盟科技(300369.SZ)公佈,公司於2020年11月5日收到公司持股5%以上股東啟迪科技服務有限公司(“啟迪科服”)轉發的《清華控股關於公開轉讓啟迪控股股份進展的通知》函件,清華控股有限公司(“清華控股”)於2020年11月5日與合肥市建設投資控股(集團)有限公司(“合肥建投”)簽訂了《產權交易合同》,清華控股擬向合肥建投轉讓其所持有的啟迪控股股份有限公司(“啟迪控股”)1.0773億股股份(佔啟迪控股總股本的14.84%)。
若此次交易實施完成,啟迪控股仍通過下屬子公司啟迪科技服務有限公司間接持有公司6006.56萬股(佔公司總股本的7.53%)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.